NPO Microgen, a company of the Naimbio holding, is launching on the market the first domestic human normal immunoglobulin for intravenous administration in the...
The investment project will be implemented in 2023–2025. The total amount of investment is estimated to be 2.6 billion rubles.
According to Nail Nizamutdinov, General...
Foreign pharmaceutical companies continue to work in Russia and supply medicines to the Russian market, Executive Director of the Association of International Pharmaceutical Manufacturers...
Binnopharm Group, a pharmaceutical company, announces its unaudited consolidated IFRS financial results for the first half ended 30 June 2022.
In 1H 2022, the Company’s...
U.S. biotech firm Moderna will build a new research and manufacturing centre in Britain to develop vaccines against new COVID-19 variants, other respiratory illnesses...
Roche and TIB Molbiol, a subsidiary within the Roche Diagnostics division, announced available testing solutions that can identify the SARS-CoV-2 B.1.1.529 variant and differentiate...